Botulinum Toxin for the Treatment of Sialorrhea: A Meta-analysis

Department of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston, South Carolina, USA.
Otolaryngology Head and Neck Surgery (Impact Factor: 1.72). 10/2012; 148(2). DOI: 10.1177/0194599812465059
Source: PubMed

ABSTRACT Objectives
Botulinum toxin has emerged as an effective approach for the management of sialorrhea. This study presents a critical literature review and meta-analysis to determine the impact of botulinum toxin on drooling severity in patients with sialorrhea.Data SourcesOvid MEDLINE and the Cochrane databases.Review Methods
The above sources were searched to identify studies examining botulinum toxin for the treatment of sialorrhea. Included studies were randomized, placebo-controlled trials. Excluded studies failed to report quantifiable outcome measures of drooling severity at 4 weeks postintervention.ResultsEight studies involving 181 patients (83 placebo; 98 active) were included in the analysis. Botulinum toxin was found to significantly decrease the severity of drooling in patients with sialorrhea (standardized mean difference [SMD], -1.54; 95% confidence interval [CI], -2.05 to -1.04; P = .06; I(2) = 48%) when compared with placebo control using random effects models. The effect was significant in both adult (SMD, -1.29; 95% CI, -1.88 to -0.71) and pediatric (SMD, -1.84; 95% CI, -2.67 to -1.00) populations. Both botulinum toxin A (SMD, -1.53; 95% CI, -2.27 to -0.79) and B (SMD, -1.56; 95% CI, -2.32 to -0.79) produced similar effects. Botulinum toxin doses greater than 50 U (SMD, -3.81; 95% CI, -6.19 to -1.43) produced much stronger effects compared with doses less than or equal to 50 U (SMD, -1.32; 95% CI, -2.28 to -0.36).Conclusion
Botulinum toxin is a clinically effective therapy that improves drooling severity in patients with sialorrhea. Future studies will need to further evaluate the technique and examine dosages required to achieve optimal outcomes.

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: Chronic sialorrhea is a common problem for pediatric patients with disorders that affect swallowing. While many patients are successfully treated with medical therapies such as Robinul and Scopolamine, a number of such children are not able to tolerate the side effects of these medications. In these cases, surgical treatments can include Botulinum toxin A (Botox) injections into the major salivary glands, sublingual or submandibular gland excision (SMGE), submandibular duct ligation, parotid duct ligation (PDL), or any combination of the above procedures. The purpose of this study is to report on the 10-year experience with the surgical management of chronic sialorrhea at one tertiary care institution, and compare the efficacy of open surgical procedures versus Botox injections for reduction in salivary flow.
    International Journal of Pediatric Otorhinolaryngology 06/2014; 78(8). DOI:10.1016/j.ijporl.2014.06.005 · 1.32 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Sialorrhea or drooling is the unintentional loss of saliva from the mouth. Considered pathological if it persists after the age of 4 years, sialorrhea is more common in patients with neurological conditions. It is typically caused by an inability to swallow saliva frequently or efficiently, rather than by an excessive production of saliva. This comprehensive review will discuss current management options used in the treatment of sialorrhea. These include rehabilitative options such as oral-motor and behavior therapy; medical treatments such as anti-cholinergics and botulinum toxin; and surgical interventions intended to either decrease salivary secretion or divert salivary flow. The plethora of possibilities is a testament to the lack of a single, universally accepted effective treatment. Controversies will be highlighted based on data in the literature as well as the author’s rich experience at a saliva management referral center.
    03/2015; 3(1). DOI:10.1007/s40136-014-0073-6
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background: The use of botulinum toxin in Otorhinolaryngology has rapidly expanded over the last decade. Current observation is that the use of botulinum toxin in Otorhinolaryngology is relatively poorly acknowledged by Otorhinolaryngologists. Objective of review: To summarise the non-cosmetic uses of botulinum toxin in Otorhinolaryngology. Type of review: Narrative. Search Strategy and evaluation method: A literature search was performed using the Medline and Embase databases. Combinations of 'botulinum toxin' with each indication were searched. A citation was included if it evaluated a non-cosmetic use of botulinum toxin in Otorhinolaryngology. Eligibility of studies was assessed by two reviewers. A total of 1187 abstracts were reviewed and 97 articles identified. Conclusions: Botulinum toxin provides an effective and minimally invasive treatment option in a wide range of non-cosmetic indications. Side-effects are few and transient with an excellent safety profile. Ongoing research is required to fully critically appraise its uses.
    Clinical otolaryngology: official journal of ENT-UK; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 06/2014; 39(4). DOI:10.1111/coa.12275 · 2.27 Impact Factor


Available from
Mar 13, 2015

Shaun A. Nguyen